Kordower JH - Search Results

1

Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models.

Song B, Cha Y, Ko S, Jeon J, Lee N, Seo H, Park KJ, Lee IH, Lopes C, Feitosa M, Luna MJ, Jung JH, Kim J, Hwang D, Cohen BM, Teicher MH, Leblanc P, Carter BS, Kordower JH, Bolshakov VY, Kong SW, Schweitzer JS, Kim KS. Song B, et al. Among authors: kordower jh. J Clin Invest. 2020 Feb 3;130(2):904-920. doi: 10.1172/JCI130767. J Clin Invest. 2020. PMID: 31714896 Free PMC article.

2

Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery.

Kordower JH, Goetz CG, Freeman TB, Olanow CW. Kordower JH, et al. Exp Neurol. 1997 Mar;144(1):41-6. doi: 10.1006/exnr.1996.6386. Exp Neurol. 1997. PMID: 9126150 Review.

3

Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.

McBride JL, Behrstock SP, Chen EY, Jakel RJ, Siegel I, Svendsen CN, Kordower JH. McBride JL, et al. Among authors: kordower jh. J Comp Neurol. 2004 Jul 19;475(2):211-9. doi: 10.1002/cne.20176. J Comp Neurol. 2004. PMID: 15211462

4

Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's disease.

Dass B, Olanow CW, Kordower JH. Dass B, et al. Among authors: kordower jh. Neurology. 2006 May 23;66(10 Suppl 4):S89-103. doi: 10.1212/wnl.66.10_suppl_4.s89. Neurology. 2006. PMID: 16717256

5

Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease.

Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K. Ghosh A, et al. Among authors: kordower jh. Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18754-9. doi: 10.1073/pnas.0704908104. Epub 2007 Nov 13. Proc Natl Acad Sci U S A. 2007. PMID: 18000063 Free PMC article.

6

Trophic factors therapy in Parkinson's disease.

Ramaswamy S, Soderstrom KE, Kordower JH. Ramaswamy S, et al. Among authors: kordower jh. Prog Brain Res. 2009;175:201-16. doi: 10.1016/S0079-6123(09)17514-3. Prog Brain Res. 2009. PMID: 19660658 Free PMC article. Review.

7

GDNF family ligands: a potential future for Parkinson's disease therapy.

Mickiewicz AL, Kordower JH. Mickiewicz AL, et al. Among authors: kordower jh. CNS Neurol Disord Drug Targets. 2011 Sep 1;10(6):703-11. doi: 10.2174/187152711797247876. CNS Neurol Disord Drug Targets. 2011. PMID: 21838676 Review.

8

Trophic factor gene therapy for Parkinson's disease.

Kordower JH, Bjorklund A. Kordower JH, et al. Mov Disord. 2013 Jan;28(1):96-109. doi: 10.1002/mds.25344. Mov Disord. 2013. PMID: 23390096 Review.

9

Immunotherapy in Parkinson's disease: Current status and future directions.

Chatterjee D, Kordower JH. Chatterjee D, et al. Among authors: kordower jh. Neurobiol Dis. 2019 Dec;132:104587. doi: 10.1016/j.nbd.2019.104587. Epub 2019 Aug 25. Neurobiol Dis. 2019. PMID: 31454546 Free article. Review.

10

Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in vivo.

Hiller BM, Marmion DJ, Gross RM, Thompson CA, Chavez CA, Brundin P, Wakeman DR, McMahon CW, Kordower JH. Hiller BM, et al. Among authors: kordower jh. Stem Cells Transl Med. 2021 Feb;10(2):278-290. doi: 10.1002/sctm.20-0014. Epub 2020 Sep 30. Stem Cells Transl Med. 2021. PMID: 32997443 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters